Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Ugeskrift for Laeger|November 8, 2017
[Upper abdominal pain caused by oesophageal perforation]Bastian Neesgaard, Anne-Sophie Sejling, Lene Arguimbau Ostenfeld-Møller
The Journal of Clinical Endocrinology and Metabolism|October 19, 2012
Syndrome of inappropriate ADH secretion and severe osteoporosisAnne-Sophie Sejling, Ulrik Pedersen-Bjergaard, Pia Eiken
The Journal of Clinical Endocrinology and Metabolism|June 28, 2014
Recovery from SIADH-associated osteoporosis: a case reportAnne-Sophie Sejling, Anne-Luise Thorsteinsson, Ulrik Pedersen-Bjergaard, et al.
Diabetes, Obesity & Metabolism|December 18, 2016
Evaluation of the counter-regulatory responses to hypoglycaemia in patients with type 1 diabetes during opiate receptor blockade with naltrexoneSarita Naik, Renata Belfort-DeAguiar, Anne-Sophie Sejling, et al.
Diabetologia|January 11, 2019
Carvedilol prevents counterregulatory failure and impaired hypoglycaemia awareness in non-diabetic recurrently hypoglycaemic ratsRawad Farhat, Gong Su, Anne-Sophie Sejling, et al.
Entropy (Basel, Switzerland)|December 8, 2020
Detection of Hypoglycemia Using Measures of EEG Complexity in Type 1 Diabetes PatientsMaria Rubega, Fabio Scarpa, Debora Teodori, et al.
Epilepsy & Behavior : E&B|September 16, 2019
An explorative literature review of the multifactorial causes of osteoporosis in epilepsySarah Seberg Diemar, Anne-Sophie Sejling, Pia Eiken, et al.
Endocrinology|December 28, 2020
Repeated Activation of Noradrenergic Receptors in the Ventromedial Hypothalamus Suppresses the Response to HypoglycemiaAnne-Sophie Sejling, Peili Wang, Wanling Zhu, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 9, 2013
ACE genotype, phenotype and all-cause mortality in different cohorts of patients with type 1 diabetesLouise H Færch, Anne-Sophie Sejling, Maria Lajer, et al.
Diabetes, Obesity & Metabolism|November 28, 2024
Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction-associated steatotic liver disease: Post hoc analysis of three randomised controlled trialsMatthew J Armstrong, Takeshi Okanoue, Mads Sundby Palle, et al.
Pageof 3